Based in Singapore, NDR Medical is developing a robotics system that uses artificial intelligence and image processing to automate the targeting of lesions and expedite the diagnosis of critical illnesses.
Chosen by an audience vote from a pool of nearly 180 early-stage medtech companies, NDR Medical was awarded the $150,000 non-dilutive grand prize to advance its business goals and mission to improve future health outcomes of patients in the region. The company was also awarded a one-year software license from Siemens Industry Software and a one-year membership to APACMed.
“We are thrilled to announce NDR Medical as the 2019 Asia Pacific Grand Prize winner,” said Paul Grand, CEO of MedTech Innovator. “Each of the four finalist companies stand to provide significant value to patients in the region, with innovations that promise to advance precision medicine, minimally invasive surgery and critical care. We are excited to follow NDR Medical's progress, along with the rest of this year's Asia Pacific Showcase companies, as they continue in the shared mission to improve outcomes and expand access to care for patients.”
Judges of the 2019 Asia Pacific final competition included Peter Hawkes, head of New Business Development, Medical Devices Asia Pacific, Johnson & Johnson; Townsend Goddard, senior vice president, global head of Business Development, Olympus; Deep Tankha, senior director of marketing, Cardiac Rhythm Management, and Endoscopy Asia Pacific, Boston Scientific; Andy Frye, senior vice president and president Asia Pacific, Baxter.
“As an industry partner of MedTech Innovator for the past seven years, it is great to see the success of this inaugural year in Asia Pacific as demonstrated by the overall quality of these four finalists and the 20 geographically diverse startups selected for the Showcase,” said Susan Morano, VP, Business Development for the Johnson & Johnson Medical Devices Companies. “We congratulate NDR Medical for winning this year’s competition and their role in bringing innovative new solutions to patients.”
Together with the senior leadership teams of its corporate partners and judges, MedTech Innovator traveled to Japan, Australia, Singapore and China to meet more than 35 candidates in person. Twenty companies were then selected to participate in the Asia Pacific Showcase program, which prominently features the most innovative medtech startups from the region. Four finalists were then chosen from the 20 Showcase companies to compete in the grand finals.